Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray

NCT05437029 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Prevention

Interventions

DRUG: Q-Griffithsin 3.0
DRUG: Q-Griffithsin 6.0

Sponsor

Kenneth Palmer

Collaborators

[object Object]